China Livzon Pharma affiliate’s COVID-19 vaccine candidate enters phase III trial
- Advertisement -
Most Popular
Asia tech stocks tumble on AI bubble fears
The downturn comes a day after a region-wide rally fuelled by an earnings report from AI bellwether Nvidia.
